Catalyst Wire Dossier Catalyst Wire Dossier

Pegylated Interferon Alfa-2b

pegylated interferon alfa-2b · F. Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for Pegylated Interferon Alfa-2b, covering 2006-05-25 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B [Phase 4]

See pricing